Swiss Market Ends Weak After Cautious Session

RTTNews | 633天前
Swiss Market Ends Weak After Cautious Session

(RTTNews) - The Switzerland stock market ended weak on Friday after swinging between gains and losses in a tight band amid cautious moves by investors.

The benchmark SMI ended with a loss of 26.34 points or 0.24% at 11,128.24. The index touched a low of 11,110.80 and a high of 11,178.04 in the session.

Alcon drifted down 2.62% and Lonza Group ended lower by 2.36%. Sika, Novartis and Swisscom closed down by 1.1 to 1.2%. Geberit, SGS and Richemont lost 0.8 to 1%.

Roche Holding gained 1.56%. The drug maker announced it has received approval from the U.S. FDA for its Xofluza drug to treat influenza in children.

Credit Suisse climbed about 1.8%. UBS Group advanced 1.2%, Swiss Re gained 0.8% and Swiss Life Holding moved up 0.6%, while Holcim and Givaudan closed with modest gains.

In the Swiss Mid Price Index, Temenos Group, Galenica Sante, Kuehne & Nagel, Lindt & Spruengli Part, Lindt & Spruengli N, VAT Group, SIG Combibloc, Schindler Holding, Tecan Group and Schindler Ps lost 2 to 3.5%.

Bachem Holding rallied 2.75%. Adecco, Clariant and Georg Fischer ended modestly higher.

read more
Jobs Data Aided Dollar's Tumble Last Week

Jobs Data Aided Dollar's Tumble Last Week

The week ended May 3 witnessed heavy losses for the Dollar as a weaker-than-expected job market update renewed hopes of a rate cut by the U.S. Federal Reserve.
RTTNews | 6小時34分鐘前
Medical Properties Stock Hit As Steward Health Files For Bankruptcy

Medical Properties Stock Hit As Steward Health Files For Bankruptcy

Medical Properties Trust, Inc.'s shares were losing around 10 percent in the initial trading on the NYSE after its tenant Steward Health Care System, the largest physician-led hospital operator in the United States, announced its filing for bankruptcy protection.
RTTNews | 6小時35分鐘前
SEC Staff To Recommend The SEC To File Enforcement Action Against Robinhood Crypto

SEC Staff To Recommend The SEC To File Enforcement Action Against Robinhood Crypto

Robinhood Markets, Inc. (HOOD) revealed on Monday in an Form 8-K filing with the U.S. Securities and Exchange Commission that Robinhood Crypto LLC or RHC, received a "Wells Notice" from the Staff of the SEC stating that the Staff has advised RHC that it made a "preliminary determination" to recommend that the SEC file an enforcement action against RHC alleging violations of Sections 15(a) and 17A of the Securities Exchange Act of 1934, as amended.
RTTNews | 6小時43分鐘前
Warren Buffett's Berkshire Hathaway Cuts Stake In Apple

Warren Buffett's Berkshire Hathaway Cuts Stake In Apple

Warren Buffett's Berkshire Hathaway has trimmed a portion of its significant stake in tech giant Apple Inc., reportedly citing tax reasons. As per its first-quarter earnings report released over the weekend, Hathaway's Apple stock was worth $135.4 billion as of March 31, 2024. This is lower than the $174.3 billion worth Apple stock as of December 31, 2023.
RTTNews | 6小時54分鐘前
Cohen & Co. Swings To Net Profit In Q1; Revenues Soar

Cohen & Co. Swings To Net Profit In Q1; Revenues Soar

Financial services company Cohen & Co. Inc. (COHN) reported Monday net income attributable to Company for the first quarter of $2.02 million or $1.28 per share, compared to a net loss of $2.64 million or $1.77 per share in the prior-year quarter.
RTTNews | 7小時15分鐘前
Eurozone Private Sector Growth Accelerates In April

Eurozone Private Sector Growth Accelerates In April

The euro area private sector growth accelerated to an 11-month high in April driven by the service sector, final survey results from S&P Global showed on Monday. The HCOB composite output index rose to 51.7 in April from 50.3 in the previous month. The flash estimate was 51.4.
RTTNews | 7小時26分鐘前
TC BioPharm Inks LOI To Acquire Privately-held CAR-T Therapy Innovator

TC BioPharm Inks LOI To Acquire Privately-held CAR-T Therapy Innovator

Biotechnology company TC BioPharm (Holdings) plc (TCBP) announced Monday the execution of a non-binding letter of intent to acquire a privately-held biotechnology company pursuing the development of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies for the treatment of refractory cancers and solid tumors.
RTTNews | 7小時46分鐘前